Angelo B. A. Laranjeira

Author

Also Known As

A B A Laranjeira, A.B.A. Laranjeira, Angelo A.B.A Laranjeira, Angelo B. A. Laranjeira, Angelo B. Laranjeira, Angelo B.A. Laranjeira, Angelo BA Laranjeira, Angelo Brunelli Albertoni Laranjeira, Angelo Laranjeira, Laranjeira, Angelo Brunelli Albertoni, 1981-

Publications

892

Citations

H-Index

Concepts

All Affiliations

Centro Infantil Boldrini Universidade Estadual de Campinas (UNICAMP)Washington University in St. Louis Centro de Pesquisas Oncológicas Universidade Federal de Santa Catarina

About

Angelo B. A. Laranjeira is an author at Centro Infantil Boldrini specializing in medicine, cell biology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	490
2	Engineering	1	1	32
3	Natural Sciences	1	1	77
4	Social Sciences	1	1	59
5	Biochemistry	1	1	77

Angelo B. A. Laranjeira

Publications

817

Citations

H-Index

Page 1

	Year	Citations
IL-7 Contributes to the Progression of Human T-cell Acute Lymphoblastic Leukemias Ana Silva, Angelo B. A. Laranjeira, Leila R. Martins, Cancer Research Hematological MalignancyMicroenvironmental FactorsAutoimmune DiseaseLymphocyte DevelopmentImmune Cell Development	2011	140
Potential Antileukemia Effect and Structural Analyses of SRPK Inhibition by N-(2-(Piperidin-1-yl)-5-(Trifluoromethyl)Phenyl)Isonicotinamide (SRPIN340) Raoni Pais Siqueira, Éverton de Almeida Alves Barbosa, Marcelo D. Polêto, PLoS ONE Pharmaceutical ScienceChemoprevention StrategySrpk InhibitionPharmacotherapyMolecular Dynamics	2015	77
Increased CCL2 and IL‐8 in the bone marrow microenvironment in acute lymphoblastic leukemia Jaira F. de Vasconcellos, Angelo B. A. Laranjeira, Nilson Ivo Tonin Zanchin, Pediatric Blood & Cancer	2010	69
DNA damage, demethylation and anticancer activity of DNA methyltransferase (DNMT) inhibitors Angelo B. A. Laranjeira, Melinda G. Hollingshead, Dat Nguyen, Scientific Reports	2023	65
Mouse lysine catabolism to aminoadipate occurs primarily through the saccharopine pathway; implications for pyridoxine dependent epilepsy (PDE) Izabella A. Pena, Lygia Azevedo Marques, Angelo B. A. Laranjeira, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease NeurophysiologyMedicineSaccharopine PathwayNeurotransmitterPyridoxine Dependent Epilepsy	2016	59
N-(1′-naphthyl)-3,4,5-trimethoxybenzohydrazide as microtubule destabilizer: Synthesis, cytotoxicity, inhibition of cell migration and in vivo activity against acute lymphoblastic leukemia Lívia B. Salum, Alessandra Mascarello, Rafael Renatino Canevarolo, European Journal of Medicinal Chemistry Medicinal ChemistryMedicineAcute Lymphoblastic LeukemiaMicrotubule DestabilizerCell Migration	2015	40
DUSP6 mediates resistance to JAK2 inhibition and drives leukemic progression Tim Kong, Angelo B. A. Laranjeira, Kangning Yang, Nature Cancer Signal TransductionSignaling PathwayReceptor Tyrosine KinaseImmunologyCell Death	2022	37
PI3K inhibition synergizes with glucocorticoids but antagonizes with methotrexate in T-cell acute lymphoblastic leukemia André Bortolini Silveira, Angelo B. A. Laranjeira, Gisele Rodrigues, Oncotarget	2015	36
IGFBP7 participates in the reciprocal interaction between acute lymphoblastic leukemia and BM stromal cells and in leukemia resistance to asparaginase Angelo B. A. Laranjeira, Jaira F. de Vasconcellos, Ladaslav Sodek, Leukemia Leukemia ResistanceHematological MalignancyMedicineMixed-phenotype Acute LeukemiaMalignant Blood Disorder	2011	32
Multiomic profiling reveals metabolic alterations mediating aberrant platelet activity and inflammation in myeloproliferative neoplasms Fan He, Angelo B. A. Laranjeira, Tim Kong, Journal of Clinical Investigation EngineeringImmunologyMyeloproliferative NeoplasmsPlatelet PathobiologyMultiomics	2023	32

Page 1